Mortality after bleeding in the head.

The old mainstay for prevention of stroke in patients with atrial fibrillation, warfarin (or Coumadin) may be further pushed aside by newer options based on the findings of a study published in the journal Stroke this month. Warfarin is a difficult drug because it requires frequent monitoring due to poor predictability of effect.